M Picard, MP Scott-Boyer, A Bodein, O Périn… - Computational and …, 2021 - Elsevier
Increased availability of high-throughput technologies has generated an ever-growing number of omics data that seek to portray many different but complementary biological …
Graph machine learning (GML) is receiving growing interest within the pharmaceutical and biotechnology industries for its ability to model biomolecular structures, the functional …
Drug development is time‐consuming and expensive. Repurposing existing drugs for new therapies is an attractive solution that accelerates drug development at reduced …
Z Zhang, L Chen, F Zhong, D Wang, J Jiang… - Current Opinion in …, 2022 - Elsevier
Developing new drugs remains prohibitively expensive, time-consuming, and often involves safety issues. Accurate prediction of drug-target interactions (DTIs) can guide the drug …
Computational drug repurposing aims to identify new indications for existing drugs by utilizing high-throughput data, often in the form of biomedical knowledge graphs. However …
Drug repositioning is a promising drug development technique to identify new indications for existing drugs. However, existing computational models only make use of lower-order …
Motivation There are various interaction/association bipartite networks in biomolecular systems. Identifying unobserved links in biomedical bipartite networks helps to understand …
P Zhang, J Chen, C Che, L Zhang, B Jin, Y Zhu - Information Sciences, 2023 - Elsevier
Graph neural networks are essential in mining complex relationships in graphs. However, most methods ignore the global location information of nodes and the discrepancy between …
Graphs are ubiquitous in nature and can therefore serve as models for many practical but also theoretical problems. For this purpose, they can be defined as many different types …